US Patent 7943586 Antineoplastic agents targeted via glut transporters
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+665 characters)
Article
Patent abstract
The present invention relates to novel antineoplastic agents and cancer diagnostic agents that specifically target neo-plastic cells via the GLUT transportation system. More specifically, the invention relates to conjugates of 2-deoxyglucose, wherein a linker, which includes a covalent bond, is attached to 2-deoxyglucose at the 2 position, and the linker is attached to a therapeutic or diagnostic agent. The invention also relates to methods of treating tumor disease and methods of making the novel compounds of the present invention. The agents of the present invention are superior to previous agents as they are targeted via GLUT transporters.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07943586 Antineoplastic agents targeted via glut transporters US Patent 7943586 Antineoplastic agents targeted via glut transporters
Infobox
Patent Number
0794358600
Patent Number
794358600
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079435860
Date of Patent
May 17, 2011
0Patent Application Number
105600750
Date Filed
June 9, 2004
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079435860
Date of Patent
May 17, 2011
0Patent Application Number
105600750
Date Filed
June 9, 2004
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07943586 Antineoplastic agents targeted via glut transporters
Infobox
Is a
Patent jurisdiction
Patent number
07943586
Date of patent
May 17, 2011
Patent application number
10560075
Date Filed
June 9, 2004
Patent primary examiner
Find more entities like US Patent 7943586 Antineoplastic agents targeted via glut transporters
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
